EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Severity and influencing factors of hyperprolactinemia in hospitalized schizophrenia patients: a cross-sectional study

Yan Yang, Li Li, Mi Yang

Frontiers in Psychiatry · 02.09.2025 · 16

DOI: 10.3389/fpsyt.2025.1658334 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Frontiers in Psychiatry, online erschienen am 02.09.2025. Verfasst von Yan Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth People's Hospital of Chengdu, Chengdu, Sichuan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Chengdu Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the severity and influencing factors of hyperprolactinemia (HPRL) in hospitalized schizophrenia patients.

Methods

This retrospective study enrolled schizophrenia inpatients from a tertiary psychiatric hospital (2022-2023) with monitored prolactin (PRL) levels. Participants were categorized into normal PRL, mild HPRL, moderate HPRL, and severe HPRL groups. Laboratory indices and medication information were collected, and an ordered logistic regression modeling was conducted to analyze the influence of HPRL severity.

Results

Among 3,641 hospitalized schizophrenia patients, 2,519 (69.18%) underwent PRL monitoring during hospitalization. A total of 1,425 patients were included for HPRL severity analysis, with 903 (63.40%) exhibiting HPRL (mild: 52.05%, moderate: 30.01%, severe: 17.94%). The mean PRL level was 983.66 ± 1001.98 mIU/L, with severe HPRL reaching 3233.66 ± 1001.98 mIU/L. The ordered multivariate logistic regression model showed that HPRL severity was negatively correlated with aripiprazole use, male sex, fasting glucose, aspartate aminotransferase (AST), and follicle-stimulating hormone (FSH), but positively correlated with the use of sulpiride, paliperidone, amisulpride, risperidone, blonanserin, trihexyphenidyl, and anxiolytics.

Conclusion

HPRL is highly prevalent in schizophrenia patients, with distinct clinical profiles across severity levels. HPRL severity is associated with specific antipsychotics, anxiolytics, trihexyphenidyl, and metabolic indicators, underscoring the need for risk stratification and individualized management.

Schlagwörter

Stichwörter der Autor:innen

antipsychoticshyperprolactinemia (HPRL)prolactinschizophreniaseverity factors

Autor:innen und Institutionen

  • The Fourth People's Hospital of Chengdu, Chengdu, Sichuan, China.
  • The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

Förderung

  • Health Commission of Chengdu Municipality

Zitieren

APA

Yang, Y., Li, L., & Yang, M. (2025). Severity and influencing factors of hyperprolactinemia in hospitalized schizophrenia patients: a cross-sectional study. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1658334

Vancouver

Yang Y, Li L, Yang M. Severity and influencing factors of hyperprolactinemia in hospitalized schizophrenia patients: a cross-sectional study. Frontiers in Psychiatry. 2025;16. doi:10.3389/fpsyt.2025.1658334

BibTeX
@article{Yang2025,
  author = {Yang, Yan and Li, Li and Yang, Mi},
  title = {Severity and influencing factors of hyperprolactinemia in hospitalized schizophrenia patients: a cross-sectional study},
  journal = {Frontiers in Psychiatry},
  year = {2025},
  volume = {16},
  doi = {10.3389/fpsyt.2025.1658334}
}
Kostenlos starten →